Printer friendly
"AcronymAttic.com

What does AAC stand for?

AAC stands for Arabinosyl-5-azacytosine

Advertisement:

This definition appears rarely

See other definitions of AAC

Other Resources: Acronym Finder has 173 verified definitions for AAC

Samples in periodicals archive:

Arabinosyl-5-azacytosine is a new compound which has been selected by the Division of Cancer Treatment, National Cancer Institute for clinical development as an antineoplastic agent based on its high degree of activity against a broad range of tumor types in preclinical studies. Therapeutic activity has been observed against murine and human leukemias, transplantable murine solid tumors, and human tumor xenografts.
Factors influencing the activity of the nucleoside analogue arabinosyl-5-azacytosine (ara-AC) were studied in P388 murine lymphoblasts in vitro and in vivo, in variants of these cells with artificially acquired resistance, in the naturally resistant colon 38 carcinoma in vivo, and in a panel of six human tumors maintained in continuous culture. Differences were noted not only between the sensitive and artificially developed resistant variants of P388, but also between the naturally sensitive (P388) and naturally resistant (colon 38) tumors.
Walters, R. S. , Theriault, R. L. , Holmes, F. A. , Hortobagyi, G. N. , & Esparza, L. (1992). Phase II trial of fazarabine (ARA-AC, arabinosyl-5-azacytosine) in metastatic breast cancer. Investigational New Drugs, 10(1), 43-44. 10.
Arabinosyl-5-azacytosine is a new compound which has been selected by the Division of Cancer Treatment, National Cancer Institute for clinical development as an antineoplastic agent based on its high degree of activity against a broad range of tumor types in preclinical studies. Therapeutic activity has been observed against murine and human leukemias, transplantable murine solid tumors, and human tumor xenografts.
Taylor, G. F. , Zamani, K. and Kepler, J. A. (1988), Synthesis of 14C and 3H labeled arabinosyl-5-azacytosine. J Label Compd Radiopharm, 25: 1073–1080. doi: 10. 1002/jlcr.
The cytocidal activity of arabinosyl-5-azacytosine (araAC) and its effect on the synthesis and methylation of DNA in the human colon carcinoma cell line HT-29 was examined and compared with three other cytidine analogues. Treatment for 2 hr with 10(-6)M arabinosylcytosine (araC), araAC, 5-azacytidine (AZC), or 2'-deoxy-5-azacytidine (dAZC) produced a 7-30% reduction in cell viability.